Print

HIVIS 03

A Phase I/II trial to assess the safety and immunogenicity of a plasmid DNA-MVA prime boost HIV-1 vaccine candidate

Trial Details:

I/II Closed to follow-up
Muhimbili University of Health and Allied Sciences, Karolinska Institute,Swedish Institute for Infectious disease Control,US Military HIV Research Program December 01, 2006
HIVIS-DNA,MVA-CMDR Env A, B and C and Rev B while pool 2 comprised plasmids encoding Gag A, B and RTmut B; Pox gag-pol CM 240, env CM235
HIVIS-DNA DNA
MVA-CMDR Viral Vector - Pox
Tanzania 60
http://www.controlled-trials.com/ISRCTN90053831